急性呼吸窘迫综合征:我选择无创通气

To treat aute respiratory distress syndrom: I prefer non-invasive ventilation

急性呼吸窘迫综合征(acute respiratory distress syndrom,ARDS)患者能否实施无创通气是存在争议的。本文参考国内外关于ARDS呼吸治疗的最新进展和临床研究,从无创通气的优势、实施途径、选择时机及风险防范方面进行了论述,验证了无创通气治疗ARDS的可行性。对于轻度ARDS、免疫抑制及手术后出现ARDS的患者,无创通气可作为一线治疗方案。

The role of non-invasive ventilation (NIV) in acute respiratory distress syndrome (ARDS) is controversial. Based on recent advances and clinical researches in ARDS therapy, this review discussed the advantage,approach of the implementation,timing, risk prevention and feasibility of NIV in treating ARDS patients. In conclusion, for patients with mild ARDS, immunosuppression and postoperative ARDS, noninvasive was used as the first-line treatment.